Geo Group Inc (The) REIT vs Heron Therapeutics Inc — how do they compare? Geo Group Inc (The) REIT trades at $30.96 (market cap $4.02B), while Heron Therapeutics Inc trades at $0.37 (market cap $74.04M). The key difference: Geo Group Inc (The) REIT is far larger — about 54.3× Heron Therapeutics Inc's market cap, and Geo Group Inc (The) REIT is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Geo Group Inc (The) REIT for 0 Days and Heron Therapeutics Inc for 35 Days on average.
| GEO | HRTX | |
|---|---|---|
Market Cap | $4.02B | $74.04M |
Volume | 2,693,825 | 3,668,095 |
Sector | Industrials | Health |
52-Week High | $32.77 | $1.49 |
52-Week Low | $13.26 | $0.27 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $5.57B | $180.78M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The GEO Group provides correctional, detention, and community reentry services. Its operations include secure facilities, electronic monitoring, and support programs for individuals in the criminal-justice system.
Read more on GEO →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →